Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05796505 · ClinicalTrials.gov registry record · NA
Addressing Vaccine Acceptance in Carceral Settings Through Community Engagement
A NA study of COVID-19, sponsored by Yale University.
- Recruiting
- Registry status
- NA
- Development phase
- 37,122
- Enrollment target
- 1
- Study location
NCT05796505: Recruiting NA study of COVID-19, sponsored by Yale University.
NCT05796505 is a NA study of COVID-19 that is actively recruiting participants, run by Yale University. The registered enrollment target is 37,122 participants, roughly in line with the 38,340-participant average among 298 other COVID-19 trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05796505, a NA study of COVID-19, is actively recruiting participants, sponsored by Yale University.
- RECRUITING
- Registry status
- NA
- Development phase
- 37,122 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to reduce morbidity and mortality from COVID-19 amongst people who are detained in and work in correctional facilities. The overall objective is to identify feasible and effective interventions to improve vaccine uptake in correctional facilities and study the effectiveness of these interventions through rapid cycle, cluster randomized trials in the Pennsylvania prison system.
Primary Outcome
COVID-19 vaccine acceptance rate amongst incarcerated people and correctional staff assessed as the number of participants that receive a COVID-19 vaccine dose or complete the COVID-19 vaccine series by electronic health record (EHR) or self report. This will apply to anyone not fully up-to-date with the full immunization series, which is defined as inclusive of boosters.
Conditions Studied
Interventions
- BEHAVIORAL ADVANCE Steering Committee interventions
Study Locations (1)
Pennsylvania
- Pennsylvannia Department of Corrections - Schwenksville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37,122 participants |
| Start Date | 2024-07-23 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
What NCT05796505 shows while recruiting
NCT05796505 is an interventional study that assigns participants to a tested intervention. Its 37,122 participants enrollment target places it among the larger protocols in the corpus, roughly in line with the 38,340-participant average among 298 other COVID-19 trials with a reported enrollment target.
The record links to 1 condition, with COVID-19 appearing as the primary indexed condition, and to 1 intervention - of which ADVANCE Steering Committee interventions is the first listed.
NCT05796505 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05796505 about?
NCT05796505 is a clinical study titled "Addressing Vaccine Acceptance in Carceral Settings Through Community Engagement". The goal of this study is to reduce morbidity and mortality from COVID-19 amongst people who are detained in and work in correctional facilities. The overall objective is to identify feasible and effective interventions to improve vaccine uptake in correctional facilities and study the effectiveness...
What is the current status of trial NCT05796505?
This trial is currently recruiting. It is a NA study. The enrollment target is 37,122 participants. The study started on 2024-07-23. Estimated completion is 2026-12-31.
What conditions does trial NCT05796505 study?
This clinical trial studies the following conditions: COVID-19.
What interventions are being tested in trial NCT05796505?
The interventions under investigation include: ADVANCE Steering Committee interventions (BEHAVIORAL).
Who is sponsoring clinical trial NCT05796505?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05796505 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for COVID-19
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05796505's enrollment target sits among peer trials
37,122 8th of 298 higher than 291 of 298 other COVID-19 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other COVID-19 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
CArdiac REhabilitation for Building Exertional heArt Rate for Chronotropic Incompetence in Long COVID-19
RECRUITING · NA
-
Music Mindfulness Study 2a.
RECRUITING · NA
-
Percutaneous Electrical Nerve Field Stimulation (PENFS) in Patients With Post Concussion Syndrome (PCS)
RECRUITING · NA
-
Impact of Aerosol Box Use During Cardiopulmonary Arrest: A Multicenter Study
RECRUITING · NA
-
Evaluating the Impact of Social Music
RECRUITING · NA
-
The SINCERE Intervention to Address COVID-19 Health Disparities
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07150923 · 36,503 participants · NA
Supraglottic Airway for Resuscitation Trial
- NCT03262259 · 36,000 participants · NA
Evaluation of Global Smart Drinking Goals Initiative
- NCT02225301 · 35,000 participants · NA
iLookOut for Child Abuse -Online Learning Module for Early Childcare Providers
- NCT03720613 · 34,532 participants
Risk of Major Adverse Cardiovascular Events for Naldemedine & Other Medications for Opioid Induced Constipation
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI